BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37668330)

  • 21. Uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
    Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
    Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelioid and spindle cell rhabdomyosarcoma with EWSR1::TFCP2 fusion mimicking metastatic lung cancer: A case report and literature review.
    Haug L; Doll J; Appenzeller S; Kunzmann V; Rosenwald A; Maurus K; Gerhard-Hartmann E
    Pathol Res Pract; 2023 Sep; 249():154779. PubMed ID: 37633005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
    Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.
    Li Y; Li D; Wang J; Tang J
    Diagn Pathol; 2023 Mar; 18(1):41. PubMed ID: 36998041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital spindle cell rhabdomyosarcoma.
    Whittle SB; Hicks MJ; Roy A; Vasudevan SA; Reddy K; Venkatramani R
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27935. PubMed ID: 31339226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.
    Sumegi J; Streblow R; Frayer RW; Dal Cin P; Rosenberg A; Meloni-Ehrig A; Bridge JA
    Genes Chromosomes Cancer; 2010 Mar; 49(3):224-36. PubMed ID: 19953635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraosseous rhabdomyosarcoma of the maxilla with TFCP2 fusion: A rare aggressive subtype with predilection for the gnathic bones.
    Silva Cunha JL; Cavalcante IL; da Silva Barros CC; Alves PM; Nonaka CFW; Albuquerque AFM; de Almeida OP; de Andrade BAB; Cavalcante RB
    Oral Oncol; 2022 Jul; 130():105876. PubMed ID: 35550988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel MEIS1-NCOA2 Gene Fusions Define a Distinct Primitive Spindle Cell Sarcoma of the Kidney.
    Argani P; Reuter VE; Kapur P; Brown JE; Sung YS; Zhang L; Williamson R; Francis G; Sommerville S; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Nov; 42(11):1562-1570. PubMed ID: 30179902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.
    Watson S; LaVigne CA; Xu L; Surdez D; Cyrta J; Calderon D; Cannon MV; Kent MR; Silvius KM; Kucinski JP; Harrison EN; Murchison W; Rakheja D; Tirode F; Delattre O; Amatruda JF; Kendall GC
    Cell Rep; 2023 Jan; 42(1):112013. PubMed ID: 36656711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.
    Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F
    Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review.
    Duan FL; Yang H; Gong X; Zuo Z; Qin S; Ji J; Zhou C; Dai J; Guo P; Liu Y
    Histopathology; 2023 Feb; 82(3):478-484. PubMed ID: 36350070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Molecular Study of Pediatric Spindle and Sclerosing Rhabdomyosarcoma: Identification of Novel and Recurrent VGLL2-related Fusions in Infantile Cases.
    Alaggio R; Zhang L; Sung YS; Huang SC; Chen CL; Bisogno G; Zin A; Agaram NP; LaQuaglia MP; Wexler LH; Antonescu CR
    Am J Surg Pathol; 2016 Feb; 40(2):224-35. PubMed ID: 26501226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggressive High-grade Uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis.
    Niu S; Rivera-Colon G; Lucas E
    Int J Gynecol Pathol; 2023 Sep; 42(5):460-465. PubMed ID: 36811835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and ALK: Report of Three New Cases in the Head and Neck Region and Literature Review.
    Gallagher KPD; Roza ALOC; Tager EMJR; Mariz BALA; Soares CD; Rocha AC; Abrahão AC; Romañach MJ; Carlos R; Hunter KD; Lopes MA; Vargas PA; Santos-Silva AR
    Head Neck Pathol; 2023 Jun; 17(2):546-561. PubMed ID: 36374445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyosarcoma With
    Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S
    Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX3-NCOA2 fusion gene has a dual role in promoting the proliferation and inhibiting the myogenic differentiation of rhabdomyosarcoma cells.
    Yoshida H; Miyachi M; Sakamoto K; Ouchi K; Yagyu S; Kikuchi K; Kuwahara Y; Tsuchiya K; Imamura T; Iehara T; Kakazu N; Hojo H; Hosoi H
    Oncogene; 2014 Dec; 33(49):5601-8. PubMed ID: 24213582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones.
    Koutlas IG; Olson DR; Rawwas J
    Head Neck Pathol; 2021 Mar; 15(1):374-380. PubMed ID: 32504289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade undifferentiated sarcoma with MEIS1::NCOA2-rearrangement primary to the lung: a case report.
    Coty-Fattal Z; Carter B; Volek MJ; Obeidin F
    Diagn Pathol; 2024 Apr; 19(1):65. PubMed ID: 38678288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.